Cardiovascular Implants Market Size Projected To Reach $36.69 Billion By 2034 With A Cagr Of 6.2%

The Cardiovascular Implants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Cardiovascular Implants Market?
In the past few years, the cardiovascular implants market has seen substantial growth. The market is projected to expand from a value of $26.8 billion in 2024 to around $28.86 billion by 2025, signifying a compound annual growth rate (CAGR) of 7.7%. Various factors have contributed to this growth in the historic period, such as the aging population and increased cardiovascular risk, cardiovascular risks related to lifestyle, advancements in diagnostic technology, heightened awareness and screening programs, and government-driven initiatives for cardiovascular health.

In the foreseeable future, we can expect the cardiovascular implants market to experience a robust growth. By 2029, it is projected to rise to a value of $36.69 billion, with a compound annual growth rate (CAGR) of 6.2%. This enlargement in the outlook period is credited to various factors - the shift toward personalized medicine, emphasis on less invasive procedures, international cooperation in cardiovascular research, preventative strategies in healthcare policies, and a patient-oriented approach in cardiovascular care. Coming trends within this period encompass advancements in drug-eluting stents, development of next-generation heart valves, the growing utilization of artificial intelligence (ai), preference for less intrusive implantation techniques, custom-made and patient-specific implants, as well as the progression of leadless pacemakers.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13399

What Are the Different Cardiovascular Implants Market Segments?
The cardiovascular implants market covered in this report is segmented -

1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:
1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp

What Are the Primary Drivers Shaping the Cardiovascular Implants Market?
The increasing incidence of heart-related ailments is anticipated to boost the cardiovascular implants market's expansion. Heart diseases encompass a range of medical issues impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The high occurrence of heart conditions like coronary artery disease and heart failure spurs the need for cardiovascular implants like stents and pacemakers for treatment. These implants assist in maintaining heart function and circulation for heart failure patients, regulate heart rhythm, and monitor heart rate. For example, a British Heart Foundation (BHF) report in September 2024 stated that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, the UK could see a rise of 1 million people living with these diseases, with a potential increase of 2 million by 2040. Hence, the growing incidence of heart disorders is fuelling the expansion of the cardiovascular implants market. An older population also enhances the growth of the cardiovascular implants market. Aging indicates a demographic transition, showing a growing portion of individuals aged 60 and above in a population. Cardiovascular implants offer effective management and treatment for cardiovascular diseases commonly found in older people, improving their quality of life, promoting longevity, and optimizing overall health outcomes. The World Health Organization reported in October 2022 that by 2030, one in every six persons worldwide is projected to be 60 or older, and the elderly population is estimated to reach 2.1 billion by 2050. Thus, the increasing population of older individuals stimulates the growth of the cardiovascular implants market.

Which Companies Are Leading in the Cardiovascular Implants Market?
Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

What Trends Are Expected to Dominate the Cardiovascular Implants Market in the Next 5 Years?
Leading firms in the cardiovascular implants industry are increasingly shifting their attention towards the adoption of sophisticated technology, specifically artificial intelligence (AI), in order to optimize their market earnings and improve patient care and treatment accuracy. The improvement in heart monitoring technology involves the constant follow-up and documentation of a patient's cardiac activity to detect and manage heart diseases. To illustrate, BIOTRONIK SE & Co. KG, a German medical technology company, initiated the first worldwide implantation of its BIOMONITOR IV, an implantable heart monitor (ICM) in June 2023. BIOMONITOR IV is an advanced ICM that blends BIOTRONIK's SmartECG technology with AI, reducing false-positive detections by a notable 86% while preserving 98% of actual events. Besides the advanced AI, BIOMONITOR IV comes with numerous other benefits for patients and healthcare professionals. A prolonged battery life and seamless wireless connectivity enable fluid data transfer and remote surveillance, lessening the necessity for regular face-to-face clinic visits.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

What Are the Top Revenue-Generating Geographies in the Cardiovascular Implants Market?
North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cardiovascular Implants Market?
2. What is the CAGR expected in the Cardiovascular Implants Market?
3. What Are the Key Innovations Transforming the Cardiovascular Implants Industry?
4. Which Region Is Leading the Cardiovascular Implants Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.